Circulation, Vol 75, 360-368, Copyright © 1987 by American Heart Association
W Berman Jr, SC Wood, SM Yabek, T Dillon, RR Fripp and R Burstein
The physiology of oxygen delivery was studied in 118 stable patients from 3
months to 20 years old with congenital heart disease. During cardiac
catheterization, oxygen consumption (VO2), arterial and venous blood gases
and oxygen saturations (range 41% to 98%), hemoglobin concentration,
diphosphoglycerate (2,3-DPG), and P50 levels were measured, and then
cardiac output, systemic oxygen transport (SOT), arterial and venous oxygen
contents, and the VO2/SOT ratio (fractional O2 extraction) were calculated.
P50 averaged 31 mm Hg, compared with 27 mm Hg in 10 control children (p
less than .01). The composite O2- hemoglobin dissociation curve in vivo was
broad: Po2 varied from 37 to 65 mm Hg at 80% saturation. P50, 2,3-DPG,
hemoglobin concentrations, and O2 saturation varied widely and
inconsistently with Po2 and arterial and venous O2 content, but resulted in
clustering of the arterial oxygen content near 165 +/- 23 (SD) ml/liter
over a wide range of Po2 and hemoglobin concentrations. SOT varied in
direct relation with flow (r = .82, p less than .001), but not with oxygen
content, Po2, or P50. VO2 varied widely at normal or high levels of SOT,
but decreased linearly at SOT levels below 400 ml/min/m2. Oxygen extraction
varied inversely with venous O2 content, rising to about 50% and plateauing
below venous contents of 100 ml/liter. O2 extraction did not correlate with
Po2, arterial O2 content, or P50. These data suggest that: O2 saturation
cannot be predicted or calculated accurately from measured Po2, but must be
measured directly, 2,3-DPG, hemoglobin concentration, and P50 fluctuate to
stabilize arterial oxygen content, SOT is determined primarily by cardiac
output in subjects who are adapted chronically, O2 extraction rises, due to
a fall in venous O2 content, to maintain VO2 as transport falls, below a
critical level of SOT, O2 extraction ceases to rise and VO2 falls with
further reduction in transport.
ARTICLES
Systemic oxygen transport in patients with congenital heart disease
This article has been cited by other articles:
![]() |
C. S. Broberg, B. E. Bax, D. O. Okonko, M. W. Rampling, S. Bayne, C. Harries, S. J. Davidson, A. Uebing, A. A. Khan, S. Thein, et al. Blood Viscosity and its Relationship to Iron Deficiency, Symptoms, and Exercise Capacity in Adults With Cyanotic Congenital Heart Disease J. Am. Coll. Cardiol., July 18, 2006; 48(2): 356 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Brunken, J. K. Perloff, J. Czernin, R. Campisi, S. Purcell, P. D. Miner, J. S. Child, and H. R. Schelbert Myocardial perfusion reserve in adults with cyanotic congenital heart disease Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1798 - H1806. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Reichenberger, J Pepke-Zaba, K McNeil, J Parameshwar, and L M Shapiro Atrial septostomy in the treatment of severe pulmonary arterial hypertension Thorax, September 1, 2003; 58(9): 797 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Barnea, W. P. Santamore, A. Rossi, E. Salloum, S. Chien, and E. H. Austin Estimation of Oxygen Delivery in Newborns With a Univentricular Circulation Circulation, October 6, 1998; 98(14): 1407 - 1413. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sandoval, J. Gaspar, T. Pulido, E. Bautista, M. L. Martinez-Guerra, M. Zeballos, A. Palomar, and A. Gomez Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension: A therapeutic alternative for patients nonresponsive to vasodilator treatment J. Am. Coll. Cardiol., August 1, 1998; 32(2): 297 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Hopkins and C. Hall Paradoxical Relationship Between N-Terminal Proatrial Natriuretic Peptide and Filling Pressure in Adults With Cyanotic Congenital Heart Disease Circulation, October 7, 1997; 96(7): 2215 - 2220. [Abstract] [Full Text] |
||||
![]() |
J. K. Perloff, M. H. Rosove, J. S. Child, and G. B. Wright Adults with Cyanotic Congenital Heart Disease: Hematologic Management Ann Intern Med, September 1, 1988; 109(5): 406 - 413. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |